Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
How Firms Are Using ICH Q12 Guideline To Reduce US FDA Oversight Of Manufacturing Changes
Feb 05 2024
•
By
Bowman Cox
more plant upgrades with less oversight delays • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance